eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease

Chorioretinitis: Follow-up

Author: Ayesha Mirza, MD, Assistant Professor, Pediatric Infectious Diseases, University of Florida College of Medicine Jacksonville
Coauthor(s): Diana E Guinazu, MD, Fellow in Pediatric Infectious Diseases, University of Florida College of Medicine
Contributor Information and Disclosures

Updated: Oct 16, 2009

Follow-up

Further Inpatient Care

  • Children with congenital infections and chorioretinitis (CR) face many possible handicaps, including partial or total loss of vision, deafness, seizure disorders, and mental retardation.
  • Short-term care for individuals with chorioretinitis includes diagnostic and management planning.
  • Management planning requires participation of several specialists included but not limited to the ophthalmologist, infectious disease specialist, neurologist, physiotherapist, and child development specialist.

Further Outpatient Care

  • Long-term care should alleviate debilitating conditions and improve functions for patients with chorioretinitis. An involved primary care physician should work closely with the specialists, the school system, and social workers.

Prognosis

  • Except when caused by congenital toxoplasmosis (CTP), prognosis for individuals with chorioretinitis depends on the originating process but tends to be self-limited.
  • Chorioretinitis due to CTP is progressive, and the outcome is not usually predictable. Late-onset retinal lesions can occur many years after birth, but the overall ocular prognosis of congenital toxoplasmosis is satisfactory when the infection is identified early and treatment is instituted appropriately.32

Patient Education

  • Aim educational efforts at reducing the incidence of primary toxoplasmosis in pregnant women. Screen pregnant women for the presence of toxoplasmosis immunoglobin (Ig)G and educate these individuals to avoid consuming undercooked meat and handling a cat litter box.
  • In the summer and fall seasons, public health measures can be used to reduce the risk of mosquito-borne viral encephalitis or tick-borne Lyme disease. During peak season for mosquitos and ticks, educate pregnant women to avoid insect bites (eg, cover up, apply insecticide to clothing items) and carry out limited larvicidal spraying to control mosquito infestation.

Miscellaneous

Special Concerns

  • Pregnant women infected with human immunodeficiency virus (HIV) are at risk of reactivation of cytomegalovirus (CMV) and, more significantly, toxoplasmosis. Reactivation of these infections can translate into higher risk of congenital infections in their infants.
 
Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Quoc V Nguyen, MD, to the original writing and development of this article.



More on Chorioretinitis

Overview: Chorioretinitis
Differential Diagnoses & Workup: Chorioretinitis
Treatment & Medication: Chorioretinitis
Follow-up: Chorioretinitis
Multimedia: Chorioretinitis
References

References

  1. Koevary SB. Ocular involvement in patients infected by the West Nile virus. Optometry. Oct 2005;76(10):609-12. [Medline].

  2. Zinkernagel MS, Bolinger B, Krebs P, Onder L, Miller S, Ludewig B. Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis. J Virol. Jan 2009;83(1):159-66. [Medline].

  3. Stagno S, Britt W, et al. Cytomegalovirus Infections. In: Remington J, Klein J, Wilson C, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier; 2006:739-81.

  4. Hall BR, Oliver GE, Wilkinson M. A presentation of longstanding toxoplasmosis chorioretinitis. Optometry. Jan 2009;80(1):23-8. [Medline].

  5. Wise ME, Sorvillo FJ, Shafir SC, Ash LR, Berlin OG. Severe and fatal central nervous system disease in humans caused by Baylisascaris procyonis, the common roundworm of raccoons: a review of current literature. Microbes Infect. Feb 2005;7(2):317-23. [Medline].

  6. Egli A, Bergamin O, Mullhaupt B, et al. Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature. Transpl Infect Dis. Feb 2008;10(1):27-43. [Medline].

  7. Greydanus DE, Noble KG, Hofmann AD. Chorioretinitis in the adolescent: two case presentations with discussion. Pediatrics. Dec 1977;60(6):884-92. [Medline].

  8. Nassetta L, Kimberlin D, Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother. May 2009;63(5):862-7. [Medline].

  9. Lopez A, Dietz VJ, Wilson M, Navin TR, Jones JL. Preventing congenital toxoplasmosis. MMWR Recomm Rep. Mar 31 2000;49:59-68. [Medline].

  10. Elsheikha HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health. Apr 2008;122(4):335-53. [Medline].

  11. Rothova A. Ocular manifestations of toxoplasmosis. Curr Opin Ophthalmol. Dec 2003;14(6):384-8. [Medline].

  12. Freeman K, Tan HK, Prusa A, et al. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics. May 2008;121(5):e1215-22. [Medline].

  13. Toxocariasis. CDC; accessed July 17, 2009. [Full Text].

  14. Woods CR. Congenital syphilis-persisting pestilence. Pediatr Infect Dis J. Jun 2009;28(6):536-7. [Medline].

  15. [Guideline] New York State Department of Health. Ophthalmologic complications of HIV infection. New York (NY): New York State Department of Health; 2004 Jan.

  16. Reed JB, Scales DK, Wong MT, Lattuada CP Jr, Dolan MJ, Schwab IR. Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae. Ophthalmology. Mar 1998;105(3):459-66. [Medline].

  17. Mikkila H, Seppala I, Leirisalo-Repo M, Immonen I, Karma A. The etiology of uveitis: the role of infections with special reference to Lyme borreliosis. Acta Ophthalmol Scand. Dec 1997;75(6):716-9. [Medline].

  18. Babu RB, Sudharshan S, Kumarasamy N, Therese L, Biswas J. Ocular tuberculosis in acquired immunodeficiency syndrome. Am J Ophthalmol. Sep 2006;142(3):413-8. [Medline].

  19. Andreola C, Ribeiro MP, de Carli CR, Gouvea AL, Curi AL. Multifocal choroiditis in disseminated Cryptococcus neoformans infection. Am J Ophthalmol. Aug 2006;142(2):346-8. [Medline].

  20. Ament CS, Young LH. Ocular manifestations of helminthic infections: onchocersiasis, cysticercosis, toxocariasis, and diffuse unilateral subacute neuroretinitis. Int Ophthalmol Clin. Spring 2006;46(2):1-10. [Medline].

  21. Chalumeau M, Monnet D, Brezin AP, et al. Chorioretinal lesions as the unique feature of complete chronic granulomatous disease in an 8-year-old girl. Eur J Pediatr. Oct 2007;166(10):1069-70. [Medline].

  22. Rigante D, Stabile A, Minnella A, et al. Post-inflammatory retinal dystrophy in CINCA syndrome. Rheumatol Int. May 8 2009;[Medline].

  23. Weiss HA. Uveitis and Chrorioretinitis. In: Long S, ed. Principles and Practice of Pediatric Infectious Diseases. 3rd ed Edition. 2008:504-8.

  24. Johannessen JK, Christiansen I, Schmidt DR, Petersen E, Hansen SH. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis. J Pharm Biomed Anal. Jan 4 2005;36(5):1093-8. [Medline].

  25. Accorinti M. Ocular bartonellosis. Int J Med Sci. 2009;6(3):131-2. [Medline].

  26. Patel SJ, Petrarca R, Shah SM, et al. Atypical Bartonella hensalae chorioretinitis in an immunocompromised patient. Ocul Immunol Inflamm. Jan-Feb 2008;16(1):45-9. [Medline].

  27. Shah CP, McKey J, Spirn MJ, Maguire J. Ocular candidiasis: a review. Br J Ophthalmol. Apr 2008;92(4):466-8. [Medline].

  28. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. Jan 2005;139(1):135-40. [Medline].

  29. Khan FA, Slain D, Khakoo RA. Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy. Dec 2007;27(12):1711-21. [Medline].

  30. Osthoff M, Hilge R, Schulze-Dobold C, Bogner JR. Endogenous endophthalmitis with azole-resistant Candida albicans--Case report and review of the literature. Infection. Oct 2006;34(5):285-8. [Medline].

  31. Prasad AG, Van Gelder RN. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol. Dec 2005;16(6):364-8. [Medline].

  32. Wallon M, Kodjikian L, Binquet C, et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics. Jun 2004;113(6):1567-72. [Medline].

Further Reading

Keywords

chorioretinitis, CR, retinochoroiditis, choroidoretinitis, congenital toxoplasmosis, CTP, congenital cytomegalovirus, CMV, congenital lymphocytic choriomeningitis virus, fungal infections, retinal vessels, infection, West Nile virus, Epstein-Barr virus, varicella-zoster virus, intrauterine growth retardation, microcephaly, microphthalmia, cataract, uveitis, hearing defect, osteomyelitis, hepatosplenomegaly, lymphadenopathy, dermal erythropoiesis, carditis, congenital heart disease, herpes simplex virus, ocular bartonellosis, infections, treatment, diagnosis

Contributor Information and Disclosures

Author

Ayesha Mirza, MD, Assistant Professor, Pediatric Infectious Diseases, University of Florida College of Medicine Jacksonville
Ayesha Mirza, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Tropical Medicine and Hygiene, HIV Medicine Association of America, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society
Disclosure: Sanofi Pasteur Honoraria Speaking and teaching

Coauthor(s)

Diana E Guinazu, MD, Fellow in Pediatric Infectious Diseases, University of Florida College of Medicine
Diana E Guinazu, MD is a member of the following medical societies: American Academy of Pediatrics and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Itzhak Brook, MD, MSc, Professor, Department of Pediatrics, Georgetown University School of Medicine
Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Mark R Schleiss, MD, American Legion Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota Medical School
Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; sanofi pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.